Market players operating in the cell dissociation is as mentioned below:
Merck KGaA
Thermo Fisher Scientific
Danaher Corp
STEMCELL Technologies
Sartorius AG
Miltenyi Biotec
PAN-Biotech
HiMedia Laboratories
F. Hoffmann-La Roche Ltd
S2 Genomics, Inc.
Nuromics.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The market size for cell dissociation reached USD 378.3 million in 2022 and is expected to grow at 15.3% CAGR from 2023 to 2032 attributed to the rising focus on the development of cell-based therapeutics and the higher development of patient-specific cell therapies.
The tissue dissociation application segment is expected to reach USD 842.5 million by 2032 attributed to applicability in wide range of research areas.
North America held 37.2% of the market in 2022 and will exhibit considerable growth 2023-2032 driven by the favorable government initiatives coupled with the presence of numerous pharmaceutical and biotechnology companies.
Merck KGaA, Thermo Fisher Scientific, Danaher Corp, STEMCELL Technologies, Sartorius AG, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd, S2 Genomics, Inc., and Nuromics are among the top companies engaged in the cell dissociation industry.